Educational resources

In this section of the Myeloma Access Atlas, you will find the results of recent research, webinars and video-interviews MPE has conducted on access, policy and regulation.

To understand the access situation within European countries, MPE has regular and open dialogue with a wide range of stakeholders including national members, advocates, patients and carers. As part of this dialogue, MPE regularly conducts different types of research to understand perceptions on access and regulation.

Survey data and research helps us to understand national patient and carer experience of diagnosis, treatment and care and how access issues are impacting on this. In addition, conducting surveys in multiple European countries allows us to compare perspectives and interventions across Europe. MPE members can also explore and use the data in this section to see how their country compares to others.

The information MPE generates from this research also feeds into the MPE European policy and public affairs area and the work we do with the pharmaceutical industry, particularly the Myeloma Community Advisory Board (Myeloma-CAB).